A collaborative partnership between breast cancer investigators and the HudsonAlpha Institute for Biotechnology Research Project has led to immunotherapy research in a type of breast cancer that affects young and minority women.
UAB oncologists and breast cancer researchers Drs. Andres Forero and Albert LoBuglio have studied two different groups of patients with triple-negative breast cancer, an aggressive, non-hormone dependent form of cancer. Because the majority of cancer drugs target hormone…
↧
